Investigators showed that GABA-receptive microglia selectively interacted with inhibitory cortical synapses during a critical window of mouse postnatal development. [Cell]
Researchers reported and characterized a long noncoding RNA, termed Brain Specific DNA-damage Related lncRNA1 (BS-DRL1), in the central nervous system. [Nature Communications]
Scientists reported that tri-methylation on lysine 40 of α-tubulin (α-TubK40me3) was required for neuronal polarization and migration by promoting microtubule formation. [Nature Communications]
Researchers reported that ventrolateral medulla (VLM) catecholaminergic neurons in the mouse brain were activated in tumor-bearing mice and the activity of these neurons significantly altered tumor growth in multiple syngeneic and spontaneous mouse tumor models. [Proceedings of the National Academy of Sciences of the United States of America]
The authors investigated mutant HTT-associated changes in gene expression by mouse and human striatal astrocytes, as well as in mouse microglia, to identify commonalities in glial pathobiology across species and models. [Cell Reports]
Scientists investigated the effects of skin precursor cell-derived Schwann cells (SKP-SCs) directly cocultured with 6-OHDA-injured dopaminergic neurons in vitro and of SKP-SCs transplanted into the brains of 6-OHDA-induced Parkinson’s disease mice in vivo. [Cell Death & Disease]
A new generation of carbonic anhydrase inhibitors and acetazolamide were investigated in two models of brain ischaemia: in rat hippocampal acute slices exposed to severe oxygen, glucose deprivation and in an in vivo model of focal cerebral ischaemia induced by permanent occlusion of the middle cerebral artery in the rat. [Journal of Enzyme inhibition and Medicinal Chemistry]
Using a c-myc amplified human medulloblastoma cell line, researchers performed an in-vitro-drug screen with single and combinatorial drugs that were either already clinically approved or agents in the advanced stage of clinical development. [Scientific Reports]
The authors focus on neural adaptations that may underlie psychostimulant-induced psychotic development and to dissect, through the sensitization process, which features are shared in bipolar disorder and other psychiatric disorders, including schizophrenia. [Translational Psychiatry]
Neurolief, Inc. and NeuroFront, Inc. jointly announced an exclusive licensing agreement for NeuroFront to develop and commercialize Relivion®, non-invasive medical devices for the treatment of migraine and depression, in Greater China and South Korea. [Neurolief, Inc. (BusinessWire, Inc.)]